Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury

Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury

Background and Aims: Fibroblast growth factor (FGF) 21 has recently been shown to play a potential role in bile acid metabolism. We aimed to investigate the FGF21 response in an ethanol-induced acute-on-chronic liver injury (ACLI) model in <i>Abcb4<sup>−/−</sup></i> mice with...

Full description

Bibliographic Details
Main Authors:	Grigorios Christidis, Ersin Karatayli, Rabea A. Hall, Susanne N. Weber, Matthias C. Reichert, Mathias Hohl, Sen Qiao, Ulrich Boehm, Dieter Lütjohann, Frank Lammert, Senem Ceren Karatayli
Format:	Article
Language:	English
Published:	MDPI AG 2021-07-01
Series:	International Journal of Molecular Sciences
Subjects:	acute-on-chronic liver failure (ACLF) alcohol-associated liver disease (AALD) ATP binding cassette subfamily B member 4 (<i>Abcb4</i>) knock-out mouse bile acid cholesterol 7α-hydroxylase (Cyp7A1) fibroblast growth factor 21 (FGF21)
Online Access:	https://www.mdpi.com/1422-0067/22/15/7898

Similar Items

Effects of pemafibrate on glucose metabolism markers and liver function tests in patients with hypertriglyceridemia: a pooled analysis of six phase 2 and phase 3 randomized double‐blind placebo‐controlled clinical trials
by: Koutaro Yokote, et al.
Published: (2021-05-01)

Enhanced GIP Secretion in Obesity Is Associated with Biochemical Alteration and miRNA Contribution to the Development of Liver Steatosis
by: Joanna Góralska, et al.
Published: (2020-02-01)

Comparing CLIF-C ACLF, CLIF-C ACLF<sub>lactate</sub>, and CLIF-C ACLF-D Prognostic Scores in Acute-on-Chronic Liver Failure Patients by a Single-Center ICU Experience
by: Chao-Cheng Kuo, et al.
Published: (2021-01-01)

Evaluation of treatment outcome in patients with acute-on-chronic liver failure using clinical scores
by: Milovanović Tamara, et al.
Published: (2020-01-01)

Chronic Over-expression of Fibroblast Growth Factor 21 Increases Bile Acid Biosynthesis by Opposing FGF15/19 Action
by: Jun Zhang, et al.
Published: (2017-02-01)

Exercise and dietary intervention ameliorate high-fat diet-induced NAFLD and liver aging by inducing lipophagy
by: Yu Gao, et al.
Published: (2020-09-01)

Pharmacological effects of fibroblast growth factor 21 are sex-specific in mice with the <em>lethal yellow</em> (A<sup>y</sup>) mutation
by: E. N. Makarova, et al.
Published: (2020-04-01)

FGF21-protection against fructose-induced lipid accretion and oxidative stress is influenced by maternal nutrition in male progeny
by: Elena Fauste, et al.
Published: (2020-01-01)

Rotational thrombelastometry (ROTEM) improves hemostasis assessment compared to conventional coagulation test in ACLF and Non-ACLF patients
by: Jessica Seeßle, et al.
Published: (2020-08-01)

Copy number gain of pro-inflammatory genes in patients with HBV-related acute-on-chronic liver failure
by: Fengming Sun, et al.
Published: (2020-12-01)

The Effect of FGF21 and Its Genetic Variants on Food and Drug Cravings, Adipokines and Metabolic Traits
by: Sarah Epperlein, et al.
Published: (2021-03-01)

Acute Hepatitis E: Two Sides of the Same Coin
by: Johannes Hartl, et al.
Published: (2016-11-01)

ChREBP Reciprocally Regulates Liver and Plasma Triacylglycerol Levels in Different Manners
by: Katsumi Iizuka, et al.
Published: (2018-11-01)

Cardioprotective Role of SIRT5 in Response to Acute Ischemia Through a Novel Liver-Cardiac Crosstalk Mechanism
by: Boda Zhou, et al.
Published: (2021-07-01)

Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury
by: Bhavna N. Desai, et al.
Published: (2017-11-01)

Hepatic AKT orchestrates adipose tissue thermogenesis via FGF21-dependent and -independent mechanisms
by: Jaimarie Sostre-Colón, et al.
Published: (2021-05-01)

Human umbilical cord-derived mesenchymal stem cells improve the function of liver in rats with acute-on-chronic liver failure via downregulating Notch and Stat1/Stat3 signaling
by: Yulin He, et al.
Published: (2021-07-01)

Genetic disruption of uncoupling protein 1 in mice renders brown adipose tissue a significant source of FGF21 secretion
by: Susanne Keipert, et al.
Published: (2015-07-01)

LPS infusion suppresses serum FGF21 levels in healthy adult volunteers
by: Esben S Lauritzen, et al.
Published: (2017-02-01)

FGF21 regulates hepatic metabolic pathways to improve steatosis and inflammation
by: Helle Keinicke, et al.
Published: (2020-08-01)

Sarcoidosis Presenting as Acute on Chronic Liver FailureReport of the First Case
by: Cyriac Abby Philips, et al.
Published: (2016-06-01)

Prognostic value of CLIF-C-ACLF scale for short-term mortality in alcoholic cirrhosis
by: N. H. Virstiuk, et al.
Published: (2018-04-01)

Spinal Cord Injury Reduces Serum Levels of Fibroblast Growth Factor-21 and Impairs Its Signaling Pathways in Liver and Adipose Tissue in Mice
by: Xin-Hua Liu, et al.
Published: (2021-05-01)

Including Fibroblast Growth Factor-21 in Combined Biomarker Panels Improves Predictions of Liver Steatosis Severity in Children
by: Man-Chin Hua, et al.
Published: (2019-10-01)

Therapeutic FGF19 promotes HDL biogenesis and transhepatic cholesterol efflux to prevent atherosclerosis[S]
by: Mei Zhou, et al.
Published: (2019-03-01)

The Intrahepatic Expression and Distribution of BTLA and its Ligand HVEM in patients with HBV-related acute-on-chronic liver failure
by: Xu Huan, et al.
Published: (2012-10-01)

Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
by: Rolf H. Zetterström, et al.
Published: (2020-08-01)

Liver Specification in the Absence of Cardiac Differentiation Revealed by Differential Sensitivity to Wnt/β Catenin Pathway Activation
by: Kim Haworth, et al.
Published: (2019-03-01)

The Significance of MicroRNAs Expression in Regulation of Extracellular Matrix and Other Drug Resistant Genes in Drug Resistant Ovarian Cancer Cell Lines
by: Dominika Kazmierczak, et al.
Published: (2020-04-01)

THE DNA-DIAGNOSTICS FORM CONGENITAL ADRENAL HYPERPLASIA CHILDREN
by: V. V. Grigoryan, et al.
Published: (2017-07-01)

Genotype/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients
by: Stefan Riedl, et al.
Published: (2019-01-01)

Comparing Eight Prognostic Scores in Predicting Mortality of Patients with Acute-On-Chronic Liver Failure Who Were Admitted to an ICU: A Single-Center Experience
by: Bo-Huan Chen, et al.
Published: (2020-05-01)

Hepatokines as a Molecular Transducer of Exercise
by: Dae Yun Seo, et al.
Published: (2021-01-01)

Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice
by: Alireza Morovat, et al.
Published: (2017-08-01)

Chlorogenic Acid Inhibits Liver Fibrosis by Blocking the miR-21-Regulated TGF-β1/Smad7 Signaling Pathway in Vitro and in Vivo
by: Fan Yang, et al.
Published: (2017-12-01)

Increased fructose consumption has sex‐specific effects on fibroblast growth factor 21 levels in humans
by: M. Rodgers, et al.
Published: (2019-10-01)

FGF19 and FGF21 for the Treatment of NASH—Two Sides of the Same Coin? Differential and Overlapping Effects of FGF19 and FGF21 From Mice to Human
by: Emma Henriksson, et al.
Published: (2020-12-01)

The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
by: Aneta Cymbaluk-Płoska, et al.
Published: (2020-06-01)

Quantitative Evaluation of Drug Resistance Profile of Cells Expressing Wild-Type or Genetic Polymorphic Variants of the Human ABC Transporter ABCC4
by: Megumi Tsukamoto, et al.
Published: (2017-07-01)

Prognostic significance of CD133 and ABCB5 expression in papillary thyroid carcinoma
by: Maria Augusta Karas Zella, et al.
Published: (2020-11-01)